Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher to Redeem $1.1B Worth of Senior Notes

NEW YORK – Thermo Fisher Scientific said today that it plans to redeem two classes of senior notes later this month that have a total aggregate principal amount of $1.1 billion.

In a filing with the US Securities and Exchange Commission, the company said it has notified the holders of its 4.7 percent senior notes that it will redeem the entire $300 million aggregate principal amount of the notes, which are due 2020. Additionally, it will redeem $800 million of its 3.15 percent senior notes, due 2023.

Both classes of notes will be redeemed on Sept. 27, Thermo Fisher said.

The 2020 notes and the 2023 notes will each be redeemed in one of two ways, whichever the greater price. The price will be either 100 percent of the principal amount of the notes or the sum of the present values of the remaining scheduled payments, discounted to the redemption data on a semi-annual basis at a comparable treasury rate plus 15 basis points, plus accrued and unpaid interest to the redemption date.

Thermo Fisher expects to finance the redemptions through issuing new debt.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.